Pharmaceutical Chemistry

Welcome Message

It is our pleasure to warmly welcome you to the 6th International Conference on Pharmaceutical Chemistry, scheduled for June 15–16, 2026, in Paris, France. Organized by Conference Series, this global event brings together leading scientists, researchers, industry specialists, and academic professionals to explore the latest advancements in pharmaceutical chemistry and drug development.

This conference offers a dynamic platform to share innovative research, discuss emerging challenges, and build meaningful collaborations that drive progress in medicinal chemistry, molecular design, and therapeutic innovation. We are confident that the sessions, presentations, and interactive discussions planned over these two days will inspire new ideas and strengthen professional connections. All the members of the 6th International Conference on Pharmaceutical Chemistry Organizing Committee look forward to welcoming you on June 15–16, 2026, in Paris, France.

About the Conference

The 6th International Conference on Pharmaceutical Chemistry, scheduled to be held on June 15–16, 2026 in Paris, France, is a premier global event bringing together leading researchers, scientists, medicinal chemists, industry experts, and academic professionals to discuss the latest advancements in drug discovery, molecular design, and pharmaceutical development. This conference aims to create a dynamic and collaborative platform where participants can exchange innovative ideas, explore emerging technologies, and address key challenges shaping the future of pharmaceutical sciences. The conference will focus on the rapidly evolving landscape of drug discovery, computational chemistry, biopharmaceuticals, green chemistry approaches, advanced analytical techniques, and targeted drug delivery systems. Delegates will gain insights into emerging technologies such as AI-driven molecule design, nanocarrier-based therapeutics, precision medicine, and sustainable pharmaceutical manufacturing.The 2026 edition continues the conference’s legacy of fostering scientific excellence and global collaboration, making it an essential gathering for professionals dedicated to improving healthcare through advancements in pharmaceutical chemistry.

Event Highlights

1. Plenary & Keynote Talks by leading global experts in pharmaceutical chemistry.

2. Scientific Sessions focused on advancements in medicinal chemistry, drug synthesis, molecular design, pharmacokinetics, and innovative drug delivery strategies..

3. Oral & Poster Presentations featuring cutting-edge research.

4. Young Researchers Forum supporting emerging scientific talent.

Why to Attend?

- Stay updated on emerging trends, technologies, and breakthroughs in pharmaceutical chemistry.

- Present your research to an international audience and receive expert feedback.

- Engage in meaningful discussions with scientists, industry leaders, and innovators.

- Discover new collaboration opportunities for future research and projects.

Join the 6th International Conference on Pharmaceutical Chemistry to explore the latest innovations in drug discovery, medicinal chemistry, and therapeutic development. Connect with global experts, share your research, gain new insights, and build valuable collaborations. This conference offers a powerful platform for learning, networking, and advancing your professional growth—all in the inspiring setting of Paris.

This event is organized by Conference Series LLC Ltd, a global leader in scientific and academic events, hosting thousands of conferences, workshops, and symposiums annually in collaboration with leading scientific associations worldwide.

Benefits of Participation

• Build strong strategic business and academic connections
• Gain cutting-edge insights into advancements in pharmaceutical biotechnology
• Collaborate with pioneers and leaders driving innovation in biopharma, drug delivery, and therapeutic development
• Participate in high-value networking sessions
• Engage in strategy-focused discussions with experts from industry and academia
• Explore specialty exhibit zones featuring the latest biotechnological tools, instruments, and solutions
• Experience the collective energy and focus of like-minded biotech professionals
• Take advantage of spontaneous learning opportunities through interactive workshops
• Join fast-paced Lightning Sessions highlighting breakthrough ideas and emerging technologies
• Witness new product launches and biotech market innovations

Reach a targeted audience of decision-makers, researchers, and industry stakeholders.

Benefits for Young Scientists:

• Premier platform to showcase your research through oral presentations
• Opportunity to share ideas with leading biotech researchers, scientists, and mentors
• Award recognition certificate and memento for selected winners
• Access to timely information, guidance, and feedback through dedicated sessions
• A collaborative environment to build networks and partnerships with fellow young researchers
• Motivation to reach higher research potential and contribute significantly to the field.

Target Audience

• Biotechnology Scientists & Researchers
• Pharmaceutical Chemists & Drug Development Experts
• Biopharmaceutical and Biomedical Engineers
• Microbiologists, Molecular Biologists, and Genetic Engineers
• Clinical Researchers & Clinical Trial Specialists
• Regulatory Affairs Professionals and QA/QC Experts
• Healthcare & Medical Professionals
• Biotech and Pharma Industry Leaders & Executives
• Academic Professors, Scholars, and Students
• Laboratory Technicians & Research Associates
• Start-ups, Innovators, and Entrepreneurs in Biotech
• Manufacturers of Bioprocessing, Analytical & Laboratory Equipment
• Investors, Venture Capitalists, and Business Strategists
• Policy Makers & Government Agencies Related to Health and Biotechnology

Tracks and Sessions

Track 1: Computational & Structural Chemistry

This track focuses on innovative in-silico methods that drive modern pharmaceutical research. It covers tools such as molecular docking, dynamics simulations, and quantum chemical calculations used to predict molecule behaviour and design more effective drug candidates. By integrating structural biology with computational modelling, this track showcases how researchers can visualize molecular interactions, improve compound stability, and accelerate the early stages of drug development.

Track 2: Phytochemicals in Drug Discovery

This track highlights the crucial role of natural products and plant-derived phytochemicals in the development of novel therapeutics. It explores how bioactive compounds from medicinal plants, marine sources, and microorganisms serve as valuable leads for drug discovery. Discussions include isolation techniques, structural characterization, biological screening, and the modification of natural molecules to enhance potency and safety. With increasing interest in sustainable and nature-inspired drug design, this track showcases how traditional knowledge, modern analytical tools, and advanced screening technologies combine to create innovative and effective drug candidates.

Track 3: Medicinal and Synthetic Chemistry

This track focuses on the design, synthesis, and optimization of bioactive molecules with therapeutic potential. It covers modern synthetic strategies, rational drug design principles, and the development of novel chemical scaffolds. Discussions include structure–activity relationships (SAR), synthetic pathway innovations, and the integration of computational tools to accelerate the creation of effective and safer drug candidates. The track highlights cutting-edge approaches that bridge synthetic chemistry with medicinal applications.

Track 4: Clinical Chemistry & Biomarkers

This track explores the chemical analysis of biological samples to support disease diagnosis, prognosis, and therapeutic monitoring. It emphasizes the discovery and validation of biomarkers that can accurately reflect physiological and pathological states. Topics include advanced analytical techniques, biochemical assay development, biomarker-based diagnostics, and their role in personalized and precision medicine. The track highlights innovative research that connects clinical laboratory science with improved patient outcomes.

Track 5: Radiopharmaceutical Chemistry

This track focuses on the design, synthesis, and application of radioactive compounds used for diagnosis and therapy. It covers radiolabeling techniques, isotope selection, and the development of targeted radiopharmaceuticals for imaging modalities such as PET and SPECT. The track highlights advancements in theranostic agents, radiometal chelation chemistry, and quality control processes essential for safety and regulatory compliance. Emphasis is placed on innovative approaches that enhance precision imaging and targeted radiotherapy for various diseases, including cancer.

Track 6: Functional Porous Materials for Drug Chemistry

This track explores the synthesis, characterization, and application of porous materials—such as zeolites, metal–organic frameworks (MOFs), and other catalytic frameworks—in pharmaceutical chemistry. These materials offer high surface area, tunable pore structures, and strong catalytic properties that support drug synthesis, separation processes, and controlled delivery systems. The session highlights innovations in material engineering, catalytic efficiency, adsorption behavior, and the development of next-generation porous platforms for sustainable and efficient pharmaceutical applications.

Track 7: Pharmaceutical Process Chemistry

This track focuses on the development and optimization of practical, scalable, and cost-effective chemical processes for manufacturing active pharmaceutical ingredients (APIs). It covers route selection, reaction optimization, impurity profiling, and process safety evaluation. Emphasis is placed on green chemistry principles, robust process design, and the transition from laboratory-scale synthesis to commercial production. The track also highlights regulatory considerations, quality control strategies, and the integration of new technologies—such as flow chemistry and automation—to enhance efficiency, sustainability, and product quality in pharmaceutical manufacturing.

Track 8: Quantum Chemistry in Drug Design

This track highlights the application of quantum mechanical principles to understand molecular behavior and accelerate drug discovery. It focuses on computational methods such as density functional theory (DFT), quantum molecular simulations, and electronic structure analysis to predict reactivity, binding interactions, and physicochemical properties of drug candidates. By enabling precise modeling of molecular energetics and interactions at the atomic level, quantum chemistry provides deeper insights into lead optimization, reaction mechanisms, and target–ligand binding. The track emphasizes emerging quantum computing tools, hybrid QM/MM approaches, and their growing role in designing more selective and efficient therapeutics.

Track 9: Stereochemical Drug Design

This track focuses on how the three-dimensional arrangement of atoms in a molecule influences its pharmacological behaviour. It highlights the importance of stereochemistry in determining drug–receptor interactions, potency, selectivity, and metabolic pathways. Discussions include enantioselective synthesis, chiral catalysts, stereoisomer separation techniques, and analytical tools used to characterize chiral compounds. The track also emphasizes regulatory considerations, safety evaluations of individual enantiomers, and modern strategies for designing stereochemically optimized therapeutic agents.

Track 10: Crystallography & Solid-State Chemistry

This track focuses on the structural and physicochemical properties of solid-state pharmaceutical materials, emphasizing how crystallography—especially X-ray diffraction—reveals molecular arrangements, polymorphs, and crystal structures that influence drug stability, solubility, and bioavailability. It covers key concepts such as polymorphism, co-crystals, amorphous forms, and salt formation, along with analytical methods and crystal engineering strategies used to predict, design, and optimize solid-state behavior. The session highlights how solid-state insights support formulation development, enhance product performance, and ensure regulatory compliance through precise characterization.

Track 11: Polymer & Material Chemistry

This track highlights the design, synthesis, and application of polymeric and advanced materials in pharmaceutical science. It covers biocompatible polymers, smart materials, hydrogels, and nanomaterials used in drug delivery, controlled release, and formulation enhancement. The session explores material properties that influence stability, solubility, and therapeutic performance, along with innovative approaches in polymer engineering, biomaterials development, and material–drug interactions. Emphasis is placed on how advanced materials enable safer, more effective, and targeted pharmaceutical solutions.

Track 12: Forensic Chemistry in Pharmaceuticals

This track focuses on the application of forensic analytical techniques to ensure the authenticity, safety, and quality of pharmaceutical products. It covers the detection of counterfeit medicines, identification of impurities and adulterants, investigation of drug tampering, and analysis of illegal or diverted pharmaceuticals. Topics include advanced spectroscopic, chromatographic, and mass spectrometric methods used to trace chemical signatures, verify formulation integrity, and support regulatory and legal investigations. The session emphasizes the role of forensic chemistry in safeguarding public health, maintaining supply-chain security, and ensuring compliance with global pharmaceutical standards.

Track 13: Microbiology & Biochemistry

This track explores the biological and biochemical foundations that support pharmaceutical research and drug development. It covers microbial systems, enzyme mechanisms, metabolic pathways, and biochemical interactions that influence drug action, efficacy, and safety. Key topics include antimicrobial resistance, pathogenic mechanisms, biochemical assays, microbial fermentation, and the use of microorganisms in producing therapeutic compounds. The session also highlights how biochemical insights and microbial studies guide the discovery of new drug targets, support vaccine development, and enhance biopharmaceutical production.

Track 14: Green & Sustainable Chemistry

This track focuses on environmentally responsible approaches to chemical synthesis and pharmaceutical manufacturing. It highlights eco-friendly reaction methods, renewable raw materials, energy-efficient processes, and waste-minimizing technologies that reduce the environmental footprint of drug production. Discussions include green solvents, catalytic alternatives, process intensification, and the application of sustainability principles in API synthesis, formulation, and packaging. The session emphasizes how adopting green chemistry enhances safety, efficiency, regulatory compliance, and long-term sustainability in the pharmaceutical industry.

Track 15: Pharmaceutical Analysis & QA/QC

This track focuses on the analytical methods and quality assurance practices essential for ensuring the safety, efficacy, and consistency of pharmaceutical products. It covers advanced analytical techniques such as chromatography, spectroscopy, and mass spectrometry used to identify and quantify drug substances, impurities, and degradation products. The session highlights method validation, stability testing, quality control procedures, and regulatory standards like GMP and ICH guidelines. Emphasis is placed on building robust analytical frameworks that support product development, manufacturing reliability, and compliance throughout the pharmaceutical lifecycle.

Track 16: Peptide & Protein Chemistry

This track focuses on the design, synthesis, modification, and characterization of peptides and proteins used as therapeutic agents. It covers solid-phase peptide synthesis, recombinant protein production, peptide engineering, and strategies to improve stability, bioavailability, and target specificity. Key discussions include peptide–protein interactions, structural analysis, folding mechanisms, and the development of biologics such as antibodies, enzymes, and peptide-based drug candidates. The session highlights innovative analytical tools and emerging technologies that drive the creation of next-generation peptide and protein therapeutics.

Track 17: Immunochemical Therapeutics

This track focuses on the chemical and molecular principles underlying modern immunotherapies and vaccine technologies. It covers the design of antigenic molecules, adjuvants, antibody-based therapeutics, and immune?modulating compounds. Key topics include antibody engineering, peptide- and carbohydrate-based immunogens, conjugate vaccines, and the chemical strategies used to enhance immune targeting, stability, and efficacy. The session also highlights emerging immunochemical approaches for cancer therapy, infectious disease prevention, and autoimmune disorder management, showcasing how chemistry drives innovation in next-generation immunotherapeutic solutions.

Track 18: Metallodrug Chemistry

This track explores the design, synthesis, and therapeutic applications of metal-based drugs and bioinorganic compounds. It highlights how metal ions and coordination complexes can offer unique reactivity, selectivity, and mechanisms of action not achievable with purely organic molecules. Key topics include anticancer metallodrugs, antimicrobial metal complexes, metal–protein interactions, redox-active therapeutics, and strategies to optimize stability, targeting, and biocompatibility. The session also covers structural characterization, ligand design, and emerging advances in metallopharmaceutical research aimed at developing more effective and innovative metal-based therapies.

Track 19: Neurochemical Therapeutics

This track focuses on the chemical and molecular mechanisms that regulate brain function and influence neurological health. It covers neurotransmitter chemistry, signaling pathways, synaptic processes, and the biochemical basis of neurological and neurodegenerative disorders such as Alzheimer’s, Parkinson’s, and epilepsy. The session highlights the design of neuroactive drugs, blood–brain barrier (BBB) targeting strategies, and biomarkers for CNS diseases. Emphasis is placed on advancing therapeutic approaches that leverage neurochemical insights to improve diagnosis, treatment, and CNS drug delivery.

Track 20: Nano-Enabled Drug Design

This track focuses on the design and application of nanoscale materials to enhance drug delivery, targeting, and therapeutic performance. It covers nanoparticles, liposomes, nanocarriers, polymeric systems, and metallic nanomaterials engineered to improve solubility, stability, and controlled release. The session highlights strategies for crossing biological barriers such as the blood–brain barrier, reducing toxicity, and increasing drug specificity. Emerging topics include nanodiagnostics, nano-bio interactions, and regulatory considerations for nanomedicine. This track showcases how nanotechnology is transforming modern drug development and precision therapeutics.

Market Overview

The global pharmaceutical chemistry market is projected to experience strong growth in 2026, driven by rapid advancements in drug discovery technologies, increasing prevalence of chronic diseases, and expanding investment in novel therapeutics, including biologics, small-molecule drugs, and personalized medicine. Continuous innovation in computational chemistry, high-throughput screening, nanotechnology-based formulations, and green chemistry is accelerating the development of safer and more efficient drug candidates. Rising R&D spending by pharmaceutical and biotech companies, coupled with supportive regulatory frameworks and the expansion of contract research organizations (CROs), further contributes to market expansion. By 2026, the market is expected to reach significant multi-billion-dollar valuation, supported by a CAGR of approximately 6–8%, reflecting strong global demand for advanced pharmaceutical solutions and cutting-edge chemical research.

•  Increased collaboration between academic institutions, pharmaceutical companies, and CROs is accelerating translational research outcomes.
• Rising focus on sustainable and eco-friendly chemical processes is reshaping manufacturing practices across the pharmaceutical sector.
• The surge in biologics, biosimilars, and targeted therapeutics is boosting demand for advanced analytical and chemical expertise.

Emerging markets in Asia-Pacific and Latin America are contributing significantly through increased manufacturing capacities and investment in R&D infrastructure.